The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2025

Filed:

Mar. 10, 2022
Applicant:

The United States of America, As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

Paul F. Robbins, Chevy Chase, MD (US);

Steven A. Rosenberg, Potomac, MD (US);

Shiqui Zhu, Potomac, MD (US);

Steven A. Feldman, Redwood City, CA (US);

Richard A. Morgan, Center Harbor, NH (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/725 (2006.01); A61K 40/11 (2025.01); A61K 40/32 (2025.01); A61K 40/42 (2025.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70503 (2013.01); A61K 40/11 (2025.01); A61K 40/32 (2025.01); A61K 40/4268 (2025.01); A61K 40/4269 (2025.01); C07K 14/7051 (2013.01); C07K 16/2803 (2013.01); G01N 33/574 (2013.01); G01N 33/57407 (2013.01); C07K 2317/73 (2013.01); C07K 2318/20 (2013.01);
Abstract

The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for a) melanoma antigen family A (MAGE A)-3 in the context of HLA-A1 or b) MAGE-A12 in the context of HLA-Cw7. The invention further provides related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells. Further provided by the invention are antibodies, or an antigen binding portion thereof, and pharmaceutical compositions relating to the TCRs of the invention. Methods of detecting the presence of cancer in a host and methods of treating or preventing cancer in a host are further provided by the invention.


Find Patent Forward Citations

Loading…